Teladoc Health (NYSE:TDOC) Price Target Increased to $10.00 by Analysts at Jefferies Financial Group

Teladoc Health (NYSE:TDOC) had its price target upped by analysts at Jefferies Financial Group from $8.00 to $10.00 in a research report issued to clients and investors on Tuesday, MarketBeat Ratings reports. The brokerage currently has a “hold” rating on the health services provider’s stock. Jefferies Financial Group’s price objective suggests a potential upside of 9.83% from the stock’s current price.

Several other equities research analysts have also issued reports on TDOC. Oppenheimer reduced their target price on shares of Teladoc Health from $21.00 to $17.00 and set an “outperform” rating for the company in a report on Thursday, August 1st. Cantor Fitzgerald reissued an “overweight” rating and issued a $10.00 target price on shares of Teladoc Health in a report on Tuesday, August 20th. Canaccord Genuity Group reduced their target price on shares of Teladoc Health from $25.00 to $17.00 and set a “buy” rating for the company in a report on Thursday, August 1st. Deutsche Bank Aktiengesellschaft reduced their target price on shares of Teladoc Health from $15.00 to $10.00 and set a “hold” rating for the company in a report on Friday, August 2nd. Finally, Truist Financial reduced their target price on shares of Teladoc Health from $15.00 to $10.00 and set a “hold” rating for the company in a report on Friday, August 2nd. Fifteen analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $12.31.

Teladoc Health Price Performance

NYSE TDOC opened at $9.11 on Tuesday. Teladoc Health has a 52 week low of $6.76 and a 52 week high of $22.54. The firm has a market capitalization of $1.54 billion, a P/E ratio of -6.64 and a beta of 0.90. The company has a quick ratio of 1.62, a current ratio of 1.66 and a debt-to-equity ratio of 0.66. The company has a 50-day moving average price of $8.05 and a 200-day moving average price of $10.98.

Teladoc Health (NYSE:TDOC) last released its quarterly earnings results on Wednesday, July 31st. The health services provider reported ($0.28) EPS for the quarter, beating the consensus estimate of ($0.36) by $0.08. Teladoc Health had a negative net margin of 38.54% and a negative return on equity of 10.25%. The firm had revenue of $642.44 million during the quarter, compared to analyst estimates of $649.34 million. Equities research analysts anticipate that Teladoc Health will post -0.73 earnings per share for the current year.

Insider Activity at Teladoc Health

In related news, insider Vidya Raman-Tangella sold 3,857 shares of the firm’s stock in a transaction on Friday, August 2nd. The shares were sold at an average price of $8.14, for a total value of $31,395.98. Following the completion of the transaction, the insider now directly owns 33,667 shares of the company’s stock, valued at $274,049.38. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. In other news, CMO Stephany Verstraete sold 15,000 shares of the stock in a transaction on Wednesday, August 7th. The shares were sold at an average price of $7.60, for a total value of $114,000.00. Following the sale, the chief marketing officer now owns 45,158 shares of the company’s stock, valued at $343,200.80. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Vidya Raman-Tangella sold 3,857 shares of the firm’s stock in a transaction dated Friday, August 2nd. The stock was sold at an average price of $8.14, for a total transaction of $31,395.98. Following the completion of the sale, the insider now owns 33,667 shares of the company’s stock, valued at approximately $274,049.38. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 57,819 shares of company stock valued at $442,204. 0.95% of the stock is owned by corporate insiders.

Institutional Trading of Teladoc Health

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. ICA Group Wealth Management LLC purchased a new position in shares of Teladoc Health during the fourth quarter valued at approximately $28,000. Signaturefd LLC lifted its stake in shares of Teladoc Health by 148.7% during the 2nd quarter. Signaturefd LLC now owns 2,868 shares of the health services provider’s stock worth $28,000 after acquiring an additional 1,715 shares during the last quarter. International Assets Investment Management LLC purchased a new position in Teladoc Health during the 2nd quarter valued at $29,000. Principal Securities Inc. bought a new position in Teladoc Health in the 4th quarter valued at $45,000. Finally, Doheny Asset Management CA bought a new position in Teladoc Health in the 2nd quarter valued at $46,000. 76.82% of the stock is owned by hedge funds and other institutional investors.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.